Advertising Disclosure — The Weight Verdict is a professional review and comparison website supported by referral fees from the companies featured on this site. Full disclosure

GLP-1 telehealth reviews, built from evidence you can check

This category has a research problem. Search for any GLP-1 program and you will find affiliate pages, paid press releases reprinted as news, and “reviews” written by competitors. We built The Weight Verdict to do the boring version instead: read the Trustpilot distribution, pull the BBB record, check the price on the company’s own checkout, and cite the FDA document by name.

Every price checked on the provider’s own siteTrustpilot + BBB, not vendor claimsAffiliate-supported and disclosedUpdated 27 July 2026

Before you read on — what "compounded" means. Compounded semaglutide and tirzepatide are not FDA-approved. The FDA has not reviewed them for safety, effectiveness, or quality, and they are not the same as the branded products your doctor may have discussed with you. In April 2026 the FDA proposed excluding semaglutide, tirzepatide and liraglutide from the 503B bulk substances list, and it has issued three waves of warning letters to telehealth marketers in this category since September 2025. Anyone comparing these programs should assume the rules may change again. This page is information, not medical advice.

Start here

Compare all three programs side by side →

Individual reviews

Program	Our score	Best for	Read
Found	4.2 / 5	People with commercial insurance that covers GLP-1s	Found review →
TrimRx	3.4 / 5	Cash payers who want supplies included in the box	TrimRx review →
bmiMD	3.2 / 5	Lowest verified price, if you accept the trade-offs	bmiMD review →

What we check, on every program

Evidence we use

Trustpilot rating and star distribution — an average of 3.5 can mean “fine” or it can mean half the customers are furious.
The company’s response rate to negative reviews.
BBB accreditation status, letter grade, complaint counts and customer review average.
Prices read off the provider’s own live pages, with the date we checked.
Refund and cancellation terms as actually published.
Named FDA documents, quoted and dated.

Evidence we refuse

Vendor-supplied member counts and star ratings in affiliate materials.
Paid press releases republished as independent news.
Countdown timers and spots-remaining counters.
“Reviews” written by a direct competitor of the company being reviewed.
Aggregator sites with no named authorship or sourcing.
Anything we cannot trace back to a source we can name on the page.

How this site makes money, in one sentence. When a reader signs up through one of our links, the program pays us a referral fee — which is why the disclosure sits at the top of every page and why our rankings are written against verifiable evidence rather than payout. The full version is here.

Before you sign up for anything

Three things are true of every program in this category, and knowing them will save you more money than any discount code:

The advertised price is almost never the ongoing price. Intro-to-renewal price shock is the single most common complaint across every company we have reviewed. Find the month-two number before you enter a card.

Compounded is not the same as branded. Compounded semaglutide and tirzepatide are not FDA-approved, and the FDA has not reviewed them for safety, effectiveness or quality. If your insurance covers branded medication, that is almost always the better route on both cost and regulatory footing.

The rules are actively changing. The FDA proposed removing semaglutide, tirzepatide and liraglutide from the 503B Bulks List on 30 April 2026, and has issued three waves of warning letters to telehealth marketers in this category since September 2025. Be careful about long prepaid commitments.